What is Protosthetics?
Protosthetics operates at the intersection of advanced additive manufacturing and patient-centric healthcare. The company specializes in in-clinic 3D printing solutions, most notably through its flagship Galileo platform. By enabling healthcare providers to perform end-to-end scanning, modeling, and printing of custom orthotics and prosthetics on-site, Protosthetics effectively eliminates the logistical bottlenecks associated with traditional outsourcing. This shift toward decentralized manufacturing not only enhances operational efficiency for clinics but also significantly reduces costs while improving the speed and quality of patient outcomes. By integrating digital workflows into the clinical setting, the firm is redefining the standard of care for mobility and support devices.
How much funding has Protosthetics raised?
Protosthetics has raised a total of $1.3M across 1 funding round:
Private Equity
$1.3M
Private Equity (2016): $1.3M, investors not publicly disclosed
Key Investors in Protosthetics
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Protosthetics?
With this major strategic investment, Protosthetics is poised to scale its research and development initiatives, focusing on the next generation of material science and software integration for the Galileo platform. The company aims to deepen its market penetration by expanding its footprint among healthcare providers who are increasingly seeking to modernize their fabrication capabilities. Future growth will likely center on enhancing the precision of its 3D printing hardware and broadening the scope of its clinical support services. As the demand for personalized medical devices continues to rise, Protosthetics is strategically positioned to lead the transition toward a more agile, digital-first model in the orthotics and prosthetics sector, ensuring that clinical providers remain at the forefront of technological innovation.
See full Protosthetics company page
